Equity of access to treatment, and barriers to treatment for illicit drug use in Australia

Addiction

Volumn 102, Issue 6, 2007, Pages 958-969

  Digiusto, Erol ^a,b   Treloar, Carla ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Australia; Behavioural model of health service utilization; Equity of treatment access; Treatment barriers

Indexed keywords

ILLICIT DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; EMOTION; FEMALE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; MENTAL DISEASE; PATIENT ATTITUDE; PREVALENCE; VIRUS INFECTION;

ADOLESCENT; ADULT; AUSTRALIA; FEMALE; HEALTH SERVICES; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34249108272     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.01842.x     Document Type: Article

References (43)

1. Cunningham J. A., Breslin F. C. Only one in three people with alcohol abuse or dependence ever seek treatment. Addict Behav 2004 29 : 221 3.
2. Popova S., Rehm J., Fischer B. An overview of illegal opioid use and health services utilization in Canada. Public Health 2006 120 : 320 8.
3. Sibthorpe B., Fleming D., Tesselaar H., Gould J., Nichols L. The response of injection drug users to free treatment on demand: implications for HIV control. Am J Drug Alcohol Abuse 1996 22 : 203.
4. Teesson M., Baillie A., Lynskey M., Manor B., Degenhardt L. Substance use, dependence and treatment seeking in the United States and Australia: a cross-national comparison. Drug Alcohol Depend 2006 81 : 149 55.
5. Wu P., Hoven C. W., Tiet Q., Kovalenko P., Wicks J. Factors associated with adolescent utilization of alcohol treatment services. Am J Drug Alcohol Abuse 2002 28 : 353 69.
6. Mattick R. P., Digiusto E., Doran C. M., O'Brien S., Shanahan M., Kimber J., et al. National Evaluation of Pharmacotherapies for Opioid Dependence. Report of Results and Recommendations. National Drug Strategy Monograph Series no. 52. Australian Government Department of Health and Ageing. Sydney : National Drug and Alcohol Research Centre. 2004
7. Digiusto E., Shakeshaft A., Ritter A., O'Brien S., Mattick R. P. for the NEPOD Research Group. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addiction 2004 99 : 450 60.
8. Pani P. P., Maremani I., Pirastu R., Tagliamonte A., Gessa G. L. Buprenorphine: a controlled clinical trial in the treatment of opioid dependence. Drug Alcohol Depend 2000 60 : 39 50.
9. Digiusto E., Shakeshaft A., Mattick R. P. for the NEPOD Research Group. Effects of pharmacotherapies for opioid dependence on participants' criminal behaviour and expenditure on illicit drugs: an Australian national evaluation (NEPOD). Aust NZ J Criminol 2006 39 : 171 89.
10. Cartwright W. S. Cost-benefit analysis of drug treatment services: review of the literature. J Mental Health Policy Econ 2000 3 : 11 26.
11. Andersen R. M. Revisiting the behavioral model and access to medical care: does it matter? J Health Social Behav 1995 36 : 1 10.
12. Gelberg L., Andersen R. M., Leake B. D. The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Serv Res 2000 34 : 1273 302.
13. Friedmann P. D., Lemon S. C., Stein M. D., D'Aunno T. A. Community referral sources and entry of treatment-naive clients into outpatient addiction treatment. Am J Drug Alcohol Abuse 2003 29 : 105 15.
14. Hser Y. I., Maglione M., Polinsky M. L., Anglin M. D. Predicting drug treatment entry among treatment-seeking individuals. J Subst Abuse Treat 1998 15 : 213 20.
15. Weisner C., Matzger H., Tam T., Schmidt L. Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance. J Stud Alcohol 2002 63 : 673 82.
16. Weisner C., Mertens J., Tam T., Moore C. Factors affecting the initiation of substance abuse treatment in managed care. Addiction 2001 96 : 705 16.
17. Ortega A. N., Alegria M. Self-reliance, mental health need, and the use of mental healthcare among island Puerto Ricans. Mental Health Serv Res 2002 4 : 131 40.
18. Arcury T. A., Gesler W. M., Preisser J. S., Sherman J., Spencer J., Perin J. The effects of geography and spatial behavior on health care utilization among the residents of a rural region. Health Serv Res 2005 40 : 135 55.
19. Desai M. M., Rosenheck R. A., Kasprow W. J. Determinants of receipt of ambulatory medical care in a national sample of mentally ill homeless veterans. Med Care 2003 41 : 275 87.
20. Andersen R., Bozzette S., Shapiro M., St Clair P., Morton S., Crystal S. et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. Health Serv Res 2000 35 : 389 416.
21. Kertesz S. G., Larson M. J., Cheng D. M., Tucker J. A., Winter M., Mullins A. et al. Need and non-need factors associated with addiction treatment utilization in a cohort of homeless and housed urban poor. Med Care 2006 44 : 225 33.
22. Kushel M. B., Gupta R., Gee L., Haas J. S. Housing instability and food insecurity as barriers to health care among low-income Americans. J Gen Intern Med 2006 21 : 71 7.
23. Saitz R., Larson M. J., Horton N. J., Winter M., Samet J. H. Linkage with primary medical care in a prospective cohort of adults with addictions in inpatient detoxification: room for improvement. Health Serv Res 2004 39 : 587 606.
24. Zule W. A., Desmond D. P. Factors predicting entry of injecting drug users into substance abuse treatment. Am J Drug Alcohol Abuse 2000 26 : 247 61.
25. Schell T. L., Orlando M., Morral A. R. Dynamic effects among patients' treatment needs, beliefs, and utilization: a prospective study of adolescents in drug treatment. Health Serv Res 2005 40 : 1128 47.
26. Treloar C., Abelson J., Cao W., Brener L., Kippax S., Schultz L. et al. Barriers and Incentives to Treatment for Illicit Drug Users. National Drug Strategy Monograph Series no. 53. Canberra : Australian Government Department of Health and Ageing 2004.
27. Dietze P., Richards J., Rumbold G., Aitken C., Day C., McGregor C. et al. Treatment Service Utilisation by Heroin Dependent Persons in Australia: Implications for Treatment Service Systems. Fitzroy, Victoria, Australia : Turning Point Alcohol and Drug Centre 2003.
28. MacDonald M., Zhou J. Prevalence of HIV, HCV and Injecting and Sexual Behaviour Among IDU at Needle and Syringe Programs: Australian NSP Survey. National data report. Sydney : National Centre in HIV Epidemiology and Clinical Research, University of New South Wales 2002, p. 1995 2001.
29. Schober R., Annis H. M. Barriers to help-seeking for change in drinking: a gender-focused review of the literature. Addict Behav 1996 21 : 81 92.
30. Farabee D., Leukefeld C. G., Hays L. Accessing drug abuse treatment: perceptions of out-of-treatment injectors. J Drug Issues 1998 28 : 381 94.
31. Neff J. A., Zule W. A. Predictive validity of a measure of treatment readiness for out-of-treatment drug users: enhancing prediction beyond demographic and drug history variables. Am J Drug Alcohol Abuse 2002 28 : 147 69.
32. Dean A. J., Bell J., Christie M. J., Mattick R. P. Depressive symptoms during buprenorphine versus methadone maintenance: findings from a randomised, controlled trial in opioid dependence. Eur Psychiatry 2004 19 : 510 13.
33. Dodge R., Sindelar J., Sinha R. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. J Subst Abuse Treat 2005 28 : 189 96.
34. Haller D. L., Miles D. R., Dawson K. S. Factors influencing treatment enrolment by pregnant substance abusers. Am J Drug Alcohol Abuse 2003 29 : 117 31.
35. Kraft M. K., Rothbard A. B., Hadley T. R., McLellan A. T., Asch D. A. Are supplementary services provided during methadone maintenance really cost-effective? Am J Psychiatry 1997 154 : 1214 9.
36. Hunter S. B., Watkins K. E., Wenzel S., Gilmore J., Sheehe J., Griffin B. Training substance abuse treatment staff to care for co-occurring disorders. J Subst Abuse Treat 2005 28 : 239 45.
37. Litwin A. H., Soloway I., Gourevitch M. N. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. Clin Infect Dis 2005 40 : S339 45.
38. Sylvestre D. L., Loftis J. M., Hauser P., Genser S., Cesari H., Borek N. et al. Co-occurring hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. J Urban Health Bull NY Acad Med 2004 81 : 719 34.
39. Dunn C., Deroo L., Rivara F. P. The use of brief motivational interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction 2001 96 : 1725 42.
40. De Jarlais D. C., Hammett T. M., Wei L., Van L. K. Opiate agonist maintenance treatment for injecting drug user peer educators. Addiction 2004 99 : 1355.
41. Vourakis C. Admission variables as predictors of completion in an adolescent residential drug treatment program. J Child Adolesc Psychiatr Nurs 2005 18 : 161 70.
42. Cunningham J. A., Sobell L. C., Gavin D. R., Sobell M. B., Breslin F. C. Assessing motivation for change: preliminary development and evaluation of a scale measuring the costs and benefits of changing alcohol or drug use. Psychol Addict Behav 1997 11 : 107 14.
43. Share D., McCrady B., Epstein E. Stage of change and decisional balance for women seeking alcohol treatment. Addict Behav 2004 29 : 525 35.